China SXT Pharmaceuticals, Inc.
SXTC
$1.46
-$0.0396-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -137.91% | -137.91% | 91.72% | 91.72% | 248.59% |
| Total Depreciation and Amortization | -86.25% | -86.25% | -33.27% | -33.27% | -28.39% |
| Total Amortization of Deferred Charges | 440.50% | 440.50% | -58.46% | -58.46% | 233.33% |
| Total Other Non-Cash Items | 117.39% | 117.39% | -99.59% | -99.59% | -307.79% |
| Change in Net Operating Assets | 67.68% | 67.68% | -336.35% | -336.35% | -159.66% |
| Cash from Operations | 26.71% | 26.71% | -134.16% | -134.16% | -387.87% |
| Capital Expenditure | 71.43% | 71.43% | -- | -- | 86.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 1,480.00% |
| Cash from Investing | 238.24% | 238.24% | 107.14% | 107.14% | 113.18% |
| Total Debt Issued | -77.46% | -77.46% | 5,815.87% | 5,815.87% | -65.95% |
| Total Debt Repaid | -419.85% | -419.85% | 98.30% | 98.30% | -93.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.77% | 38.77% | -- | -- | 74.43% |
| Cash from Financing | -36.76% | -36.76% | 262.20% | 262.20% | -86.89% |
| Foreign Exchange rate Adjustments | -597.60% | -597.60% | 158.40% | 158.40% | 390.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.63% | -162.63% | 209.02% | 209.02% | -95.74% |